Assessment and management of chronic hepatitis B = Estimation et maîtrise de l'hépatite chronique BNAOUMOV, Nikolai V.Clinical medicine. 2002, Vol 2, Num 4, pp 306-310, issn 1470-2118, 5 p.Article

Individualization of antiviral treatment regimens for chronic hepatitis C : Hepatitis C in 2006PAULON, Emma; NAOUMOV, Nikolai V.European journal of gastroenterology & hepatology. 2006, Vol 18, Num 4, pp 321-325, issn 0954-691X, 5 p.Article

The potential of RNA interference as a tool in the management of viral hepatitisTAYLOR, John A; NAOUMOV, Nikolai V.Journal of hepatology. 2005, Vol 42, Num 1, pp 139-144, issn 0168-8278, 6 p.Article

Is hepatitis C virus infection of dendritic cells a mechanism facilitating viral persistence?PACHIADAKIS, Ioannis; POLLARA, Gabriele; CHAIN, Benjamin M et al.Lancet. Infectious diseases (print). 2005, Vol 5, Num 5, pp 296-304, issn 1473-3099, 9 p.Article

Presence of hepatitis B virus core promoter mutations pre-seroconversion predict persistent viral replication after HBeAg lossBRIDGET FERNS, R; NAOUMOV, Nikolai V; GILSON, Richard J et al.Journal of clinical virology. 2007, Vol 39, Num 3, pp 199-204, issn 1386-6532, 6 p.Article

Blocking of interleukin-10 receptor : a novel approach to stimulate T-helper cell type 1 responses to hepatitis C virusRIGOPOULOU, Eirini I; ABBOTT, William G. H; HAIGH, Philip et al.Clinical immunology (Orlando, Fla. Print). 2005, Vol 117, Num 1, pp 57-64, issn 1521-6616, 8 p.Article

Novel immunoassay for the detection of hepatitis B surface 'escape' mutants and its application in liver transplant recipientsIJAZ, Samreen; TORRE, Francesco; TEDDER, Richard S et al.Journal of medical virology. 2001, Vol 63, Num 3, pp 210-216, issn 0146-6615Article

APOBEC and iNOS are not the main intracellular effectors of IFN-γ-mediated inactivation of Hepatitis B virus replicationPROTO, Sandra; TAYLOR, John A; CHOKSHI, Shilpa et al.Antiviral research. 2008, Vol 78, Num 3, pp 260-267, issn 0166-3542, 8 p.Article

Direct evidence for immunomodulatory properties of ribavirin on T-cell reactivity to hepatitis C virusRIGOPOULOU, Eirini I; ABBOTT, William G. H; WILLIAMS, Roger et al.Antiviral research. 2007, Vol 75, Num 1, pp 36-42, issn 0166-3542, 7 p.Article

Lamivudine plus interleukin-12 combination therapy in chronic hepatitis B : Antiviral and immunological activityRIGOPOULOU, Eirini I; SURI, Deepak; CHOKSHI, Shilpa et al.Hepatology (Baltimore, Md.). 2005, Vol 42, Num 5, pp 1028-1036, issn 0270-9139, 9 p.Article

Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis CPHAM, Tram N. Q; MACPARLAND, Sonya A; MULROONEY, Patricia M et al.Journal of virology. 2004, Vol 78, Num 11, pp 5867-5874, issn 0022-538X, 8 p.Article

Novel Mechanism of Antibodies to Hepatitis B Virus in Blocking Viral Particle Release from CellsNEUMANN, Avidan U; PHILLIPS, Sandra; LEVINE, Idit et al.Hepatology (Baltimore, Md.). 2010, Vol 52, Num 3, pp 875-885, issn 0270-9139, 11 p.Article

Hepatitis C Virus (HCV)-Specific T Cell Responses in Injection Drug Users with Apparent Resistance to HCV InfectionTHURAIRAJAH, Prem H; HEGAZY, Doha; CHOKSHI, Shilpa et al.The Journal of infectious diseases. 2008, Vol 198, Num 12, pp 1749-1755, issn 0022-1899, 7 p.Article

Relationship between early HCV kinetics and T-cell reactivity in chronic hepatitis C genotype 1 during peginterferon and ribavirin therapyTANG, Kwok H; HERRMANN, Eva; COOKSLEY, Helen et al.Journal of hepatology. 2005, Vol 43, Num 5, pp 776-782, issn 0168-8278, 7 p.Article

Non-cytolytic inhibition of hepatitis B virus replication in human hepatocytesSURI, Deepak; SCHILLING, Ralf; LOPES, Agnel R et al.Journal of hepatology. 2001, Vol 35, Num 6, pp 790-797, issn 0168-8278Article

Direct evidence that naturally occurring mutations within hepatitis B core epitope alter CD4+ T-cell reactivityTORRE, Francesco; CRAMP, Matthew; OWSIANKA, Ania et al.Journal of medical virology. 2004, Vol 72, Num 3, pp 370-376, issn 0146-6615, 7 p.Article

Dynamics of Lamivudine-Resistant Hepatitis B Virus During Adefovir Monotherapy Versus Lamivudine Plus Adefovir Combination TherapyIJAZ, Samreen; ARNOLD, Catherine; DERVISEVIC, Samir et al.Journal of medical virology. 2008, Vol 80, Num 7, pp 1160-1170, issn 0146-6615, 11 p.Article

Programmed Death 1 Expression During Antiviral Treatment of Chronic Hepatitis B : Impact of Hepatitis B e-Antigen SeroconversionEVANS, Alexander; RIVA, Antonio; COOKSLEY, Helen et al.Hepatology (Baltimore, Md.). 2008, Vol 48, Num 3, pp 759-769, issn 0270-9139, 11 p.Article

Novel type of hepatitis B virus mutation : Replacement mutation involving a hepatocyte nuclear factor 1 binding site tandem repeat in chronic hepatitis B virus genotype EFUJIWARA, Kei; TANAKA, Yasuhito; PAULON, Emma et al.Journal of virology. 2005, Vol 79, Num 22, pp 14404-14410, issn 0022-538X, 7 p.Article

Early viraemia clearance during antiviral therapy of chronic hepatitis C improves dendritic cell functionsPACHIADAKIS, Ioannis; CHOKSHI, Shilpa; COOKSLEY, Helen et al.Clinical immunology (Orlando, Fla. Print). 2009, Vol 131, Num 3, pp 415-425, issn 1521-6616, 11 p.Article

Comparison of real-time PCR assays for monitoring serum hepatitis B virus DNA levels during antiviral therapyHUI, Chee-Kin; BOWDEN, Scott; LEUNG, Nancy et al.Journal of clinical microbiology (Print). 2006, Vol 44, Num 8, pp 2983-2987, issn 0095-1137, 5 p.Article

Kinetics of Hepatitis B Surface Antigen Decline During 3 Years of Telbivudine Treatment in Hepatitis B e Antigen-Positive PatientsWURSTHORN, Karsten; JUNG, Mechthild; RIVA, Antonio et al.Hepatology (Baltimore, Md.). 2010, Vol 52, Num 5, pp 1611-1620, issn 0270-9139, 10 p.Article

Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis BZEUZEM, Stefan; GANE, Edward; NGUYEN, Tuan T et al.Journal of hepatology. 2009, Vol 51, Num 1, pp 11-20, issn 0168-8278, 10 p.Article

Impact of early viral kinetics on T-cell reactivity during antiviral therapy in chronic hepatitis BLAU, George K. K; COOKSLEY, Helen; ROUSSEAU, Franck et al.Antiviral therapy (London). 2007, Vol 12, Num 5, pp 705-718, issn 1359-6535, 14 p.Article

High serum IL-21 levels after 12 weeks of antiviral therapy predict HBeAg seroconversion in chronic hepatitis BMA, Shi-Wu; XUAN HUANG; DONG, Yu-Hong et al.Journal of hepatology. 2012, Vol 56, Num 4, pp 775-781, issn 0168-8278, 7 p.Article